Esin C. Namoglu

Hospitalization Patterns with Commercial CAR T-Cell Therapy: A Single Institution Experience

Sunita D. Nasta, Esin C. Namoglu, Mitchell E. Hughes et al. · Blood · 2019 · 20 citations

Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma With Venetoclax: A Single-Center Evaluation of Off-Label Use

Mitchell E. Hughes, Daniel J. Landsburg, Daniel J. Rubin et al. · Clinical Lymphoma Myeloma & Leukemia · 2019 · 16 citations

Lymphoid Neoplasia, Surgical Oncology, Single-center Evaluation +6

A Characterization of Bridging Therapies Leading up to Commercial CAR T-Cell Therapy

Sunita D. Nasta, Mitchell E. Hughes, Esin C. Namoglu et al. · Blood · 2019 · 16 citations

Outcomes of Tisagenlecleucel in Lymphoma Patients With Predominant Management in an Ambulatory Setting

Sunita D. Nasta, Mitchell E. Hughes, Esin C. Namoglu et al. · Clinical Lymphoma Myeloma & Leukemia · 2022 · 15 citations · Full text

Lymphoid Neoplasia, Ambulatory Setting, Hematology +5

Use of Bendamustine for Lymphodepletion before Tisagenlecleucel (anti-CD19 CAR T cells) for Aggressive B-Cell Lymphomas

Jakub Svoboda, Hatcher J. Ballard, Elise A. Chong et al. · Blood · 2019 · 12 citations